Serum trough levels of infliximab are not associated with peripheral arthralgia activity in patients with inflammatory bowel disease

BACKGROUND: Infliximab is an efficacious therapy for inflammatory bowel disease and may play a role in management of some extraintestinal manifestations. While higher trough levels of infliximab are associated with higher rates of disease remission, the association between trough levels of inflixima...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekhri, Shaina, Rao, Bharat, Mohananey, Akanksha, Beniwal-Patel, Poonam, Bruss, Alexandra, Stein, Daniel J, Yarur, Andres J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587383/
https://www.ncbi.nlm.nih.gov/pubmed/34764142
http://dx.doi.org/10.1136/bmjgast-2021-000788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587383/
https://www.ncbi.nlm.nih.gov/pubmed/34764142
http://dx.doi.org/10.1136/bmjgast-2021-000788

Ejemplares similares